Larvol Delta - FDA-Removes-Partial-Clinical-Hold-on-TakeAim-Leukemia-Study-RP2D-Established-at-300-mg-BID

emavusertib (CA-4948) - Curis, Dr. Reddy’s

https://www.prnewswire.com/news-releases/fda-removes-partial-clinical-hold-on-takeaim-leukemia-study-rp2d-established-at-300-mg-bid-301870902.html

Jul 6, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next